AstraZeneca PLC (AZN) Debt/EBITDA US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| Debt/EBITDA | 4.75 | 2.52 | 1.70 | 1.59 | 1.21 | 1.28 | |||
| Changes by years, y/y, % | +210% | -47% | -33% | -6% | -24% | -4.6% | |||
AstraZeneca PLC. Debt/EBITDA
AstraZeneca PLC. Debt/EBITDA, changes, %
AstraZeneca PLC (AZN) Debt/EBITDA US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| Debt/EBITDA | 1.64 | 1.52 | 1.36 | 1.21 | 1.28 | 1.28 | ||
| Changes by years, y/y, % | -12% | -16% | -22% | -23% | -22% | |||
| Changes by quarters, q/q, % | +4% | -7% | -11% | -11% | +6% | |||